Gentulizumab in Patients With Advanced Solid Malignancies and Non-Hodgkin Lymphoma

NCT05221385 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

58

Enrollment

INDUSTRY

Sponsor class

Stopped Due to changes in the sponsor's research strategy

Conditions

Solid Tumor
Non-Hodgkin Lymphoma

Interventions

DRUG: Gentulizumab

Sponsor

Changchun GeneScience Pharmaceutical Co., Ltd.